Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.965
+0.027 (2.86%)
At close: Mar 6, 2026, 4:00 PM EST
0.965
0.00 (0.00%)
After-hours: Mar 6, 2026, 4:00 PM EST
Senti Biosciences Stock Forecast
SNTI's stock price has decreased by -70.91% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Senti Biosciences stock have an average target of 9.00, with a low estimate of 5.00 and a high estimate of 13. The average target predicts an increase of 832.74% from the current stock price of 0.96.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 9, 2025.
Analyst Ratings
The average analyst rating for Senti Biosciences stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 → $13 | Strong Buy | Maintains | $12 → $13 | +1,247.29% | Dec 9, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $6 | Buy | Initiates | $6 | +521.83% | Nov 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +1,143.65% | Oct 14, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +1,143.65% | Aug 8, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +1,143.65% | Jun 12, 2025 |
Financial Forecast
Revenue This Year
680.00K
Revenue Next Year
1.70M
from 680.00K
Increased by 150.00%
EPS This Year
-2.70
from -12.03
EPS Next Year
-1.44
from -2.70
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 2.1M | 5.3M | ||||
| Avg | 680,003 | 1.7M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 672.1% | ||||
| Avg | - | 150.0% | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.12 | -0.90 | ||||
| Avg | -2.70 | -1.44 | ||||
| Low | -2.84 | -1.87 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.